Clinical Trial Update: Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers

View source ↗

Summary

This is a completed clinical trial evaluating non-small cell lung cancer using predefined drug-targeting tumor markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Lung Cancer | Status: COMPLETED